Egypt Basyouni Abuseif, country president and CPO Head at Novartis Egypt, explains how the Swiss company has taken over the leadership position in the Egyptian pharmaceutical market despite economic and political challenges. He also highlights recent achievements of the government in fighting Hepatitis C, while emphasizing the need for more attention…
France Claude Le Pen, a prominent healthcare economist and consultant for IQVIA, shares his view on the state of French and European social dynamics today and outlines the key trends shaping France’s healthcare and life sciences sectors. The intent of the government to transform the healthcare system is a step…
France Christophe Lala, general manager of western Europe for GE Healthcare offers an overview of the current dynamics impacting the French healthcare landscape – namely a shift in structure around care pathways and the hot trend of digitalization. Lala goes on to assess France’s willingness and capability to embrace this technology,…
Egypt After months of discussion, in December 2017 Egypt’s Parliament approved a new national health insurance law that aims to overcome some of the inherent problems in the current healthcare system and offer better medical services to the public. We have studied enough, the time for implementation is now! Dr…
Opinion The Foundations for Evidence-Based Policy-Making Act, recently signed into law in the USA, stands to make government data more accessible; thereby allowing researchers, statisticians and others inside and outside of government to make better, and evidenced-based, policy decisions. Carla Smith outlines the scope of the Act and its potential implications…
Malaysia Eurasia Group’s Aditya Bhattacharji discusses the relatively modest scope of Malaysia’s recently-launched ‘MYSalam’ scheme; a healthcare programme which aims to provide coverage to the country’s bottom 40 percent of earners. For the time being, the outlook for the private sector, including for pharmaceutical firms, is good Another populist government,…
China Research has established that proper nutrition during hospitalization helps to reduce the number of infections, the duration of treatment needed for recovery, and reduce the readmission rateCecily Gu discusses her move from traditional pharma to a broader healthcare company, the significance of the Greater China region to the global Nestlé…
WHO Brendan Shaw outlines how a new approach to the WHO’s Essential Medicines List is needed to ensure both the patients of today and of the future can access the medicines they need. For pharmaceutical companies, listing on the EML can be a double-edged sword. More than 40 years after its…
Egypt Rates of tuberculosis (TB) have dropped dramatically in Egypt over the last 30 years, but there is still work to be done, with the country’s Ministry of Health recently announcing a new campaign to combat the prevalence of the disease Thanks to the rollout of a national anti-TB programme,…
Korea Steve Hong, CEO, and Tony Lim, vice president & COO of Lemon Healthcare, lift the lid on the new streamlined hospital data services they are offering, and the benefits to speed and cost effectiveness that they will bring to healthcare providers and patients. Lim also reveals his strategy to expand…
Diversity Annually, PharmaBoardroom conducts hundreds of interviews with global CEO’s, country managers and industry leaders in the pharma industry. While we have crossed paths with many inspiring females in these positions, out of the top 50 pharma companies, only 3 are headed by women. That is a mere 6% — this…
Spain Having largely recovered from the impact of the global financial crisis and with several impressive fundamentals in place, Spain once again stands as one of Europe’s premier healthcare and life science investment destinations. These fundamentals include a revamped market access process that puts the Iberian nation on a par…
See our Cookie Privacy Policy Here